KROS Keros Therapeutics, Inc. - common stock
NASDAQ · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 3, 2026
$11,36
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,6952-Wochen-Tief
$22,5552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$225M
P/E (TTM)
-3.5
EPS (TTM)
$-3.22
Umsatz (TTM)
$15M
Ihre Abzeichen
52W-Spanne
$10–$23
Analystenbewertung
BUY
Kursziel
$20
P/E
-3.5
ROE
-17.2%
Nettogewinnmarge
-572.1%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
KROS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$11.36
Marktkapitalisierung (MRQ)
$225M
P/E (TTM)
-3.5
EPS (TTM)
$-3.22
Umsatz (TTM)
$15M
ROE (TTM)
-17.2%
52W-Spanne
$10–$23
KROS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$244M2019-12-31 → 2025-12-31
EPS$2.302020-12-31 → 2025-12-31
Freier Cashflow$106M2020-12-31 → 2025-12-31
Nettogewinnmarge-572.1%2021-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | KROS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -3.55-Jahres-Durchschnitt ≈-7.3 | ≈-7.3 | · | · | |
| P/S (TTM) | 15.55-Jahres-Durchschnitt ≈2818.5 | ≈2818.5 | 16.2 | Fairer Wert | |
| K/B (MRQ) | 0.95-Jahres-Durchschnitt ≈3.4 | ≈3.4 | 2.1 | Unterbewertet | |
| Kurs / FCF (TTM) | -4.65-Jahres-Durchschnitt ≈-10.2 | ≈-10.2 | · | · | |
| Kurs / Cashflow (TTM) | -4.75-Jahres-Durchschnitt ≈-10.4 | ≈-10.4 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 0.75-Jahres-Durchschnitt ≈3.4 | ≈3.4 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | KROS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -698.0%5-Jahres-Durchschnitt ≈-29683.9% | ≈-29683.9% | -734.7% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | 27.7%5-Jahres-Durchschnitt ≈-29683.9% | ≈-29683.9% | -734.7% | Schwach | |
| Vorgewinnmarge (TTM) | -592.3%5-Jahres-Durchschnitt ≈-26708.2% | ≈-26708.2% | -840.0% | Schwach | |
| Nettogewinnmarge (TTM) | -572.1%5-Jahres-Durchschnitt ≈-26713.3% | ≈-26713.3% | -692.5% | Schwach | |
| ROA (TTM) | -15.9%5-Jahres-Durchschnitt ≈-24.9% | ≈-24.9% | -36.6% | Spitzenklasse | |
| ROE (TTM) | -17.2%5-Jahres-Durchschnitt ≈-26.2% | ≈-26.2% | -35.5% | Spitzenklasse | |
| ROIC | 21.1%5-Jahres-Durchschnitt ≈-26.5% | ≈-26.5% | 21.1% | Im Einklang |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | KROS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 22.05-Jahres-Durchschnitt ≈17.9 | ≈17.9 | 5.4 | Starke Liquidität | |
| Quick Ratio | 14.35-Jahres-Durchschnitt ≈17.2 | ≈17.2 | 5.1 | Starke Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
Für diese Kennzahlengruppe sind noch keine Daten verfügbar
Noch nicht genügend Fundamentaldaten vorhanden, um diese Kennzahlengruppe zu berechnen.
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | KROS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.1 | ≈0.1 | 0.1 | Spitzenklasse | |
| Receivables Turnover (Forderungsumschlag) | 77.35-Jahres-Durchschnitt ≈16.8 | ≈16.8 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$2.7M | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
270.2%
Nächster Bericht
Nov 03, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-1.45 | $-1.37 | -6.1% |
| 31. März 2026 | Mai 14, 2026 | $-1.21 | $-1.04 | -16.0% |
| 31. Dezember 2025 | $-0.86 | $-0.64 | -34.1% | |
| 30. September 2025 | $-0.18 | $-1.07 | 83.1% | |
| 30. Juni 2025 | $-0.76 | $-1.15 | 34.2% | |
| 31. März 2025 | $3.62 | $-0.25 | 1560.3% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $244M | $0 | $151.0K | $0 | $20M | $0 | $10M | |
| R&D Expense | $130M | $174M | $135M | $87M | $55M | $34M | $17M | |
| SG&A Expense | $47M | $41M | $35M | $28M | $21M | $13M | $3M | |
| Operating Expenses | $176M | $214M | $170M | $115M | $76M | $47M | $21M | |
| Operating Income | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | $-11M | |
| Other Non-op | $-539.0K | $-954.0K | $-206.0K | $-613.0K | $-383.0K | $160.0K | $241.0K | |
| Pretax Income | $92M | $-187M | $-153M | $-105M | $-57M | $-46M | $-12M | |
| Income Tax | $5M | $300.0K | $0 | $0 | $2M | $-172.0K | $0 | |
| Net Income | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | $-12M | |
| EPS (Basic) | $2.34 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| EPS (Diluted) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · | |
| Shares (Basic) | 37,221,211 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| Shares (Diluted) | 37,859,106 | 37,437,652 | 29,447,119 | 25,241,030 | 23,333,914 | 15,506,397 | · | |
| EBITDA | $68M | $-211M | $-170M | $-115M | $-56M | $-47M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $287M | $560M | $331M | $279M | $230M | $266M | $7M | |
| Receivables | $4M | $3M | $143.0K | $0 | $18M | $0 | · | |
| Prepaid Expense | $22M | $26M | $16M | $7M | $3M | $2M | $381.0K | |
| Other Current Assets | $2M | $1M | $1M | $276.0K | $210.0K | $160.0K | $215.0K | |
| Current Assets | $315M | $589M | $347M | $286M | $251M | $268M | $9M | |
| PP&E (Net) | $4M | $4M | $4M | $2M | $1M | $724.0K | $708.0K | |
| PP&E (Gross) | $9M | $7M | $6M | $3M | $2M | $1M | $1M | |
| Accum. Depreciation | $4M | $3M | $2M | $1M | $846.0K | $721.0K | $453.0K | |
| Other Non-current Assets | $0 | $2M | $2M | $2M | $82.0K | $0 | · | |
| Total Assets | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Accounts Payable | $2M | $5M | $5M | $3M | $4M | $2M | $2M | |
| Accrued Liabilities | $16M | $21M | $18M | $13M | $7M | $5M | $2M | |
| Current Liabilities | $20M | $27M | $24M | $17M | $12M | $7M | $4M | |
| Capital Leases | $14M | $17M | $13M | $13M | $231.0K | $476.0K | $899.0K | |
| Other Non-current Liabilities | · | · | · | · | $0 | $62.0K | $119.0K | |
| Total Liabilities | $35M | $44M | $38M | $29M | $12M | $8M | $10M | |
| Common Stock | $4.0K | $4.0K | $3.0K | $2.0K | $2.0K | $2.0K | $1.0K | |
| Paid-in Capital | $1.17B | $1.14B | $714M | $506M | $367M | $327M | $203.0K | |
| Retained Earnings | $-482M | $-569M | $-381M | $-228M | $-124M | $-65M | $-20M | |
| Treasury Stock | $385M | $0 | · | · | · | · | · | |
| Stockholders' Equity | $303M | $572M | $332M | $277M | $243M | $262M | $-19M | |
| Liabilities + Equity | $338M | $616M | $370M | $307M | $255M | $269M | $11M | |
| Shares Outstanding | 19,543,706 | 40,554,705 | 31,841,084 | 27,543,453 | 23,974,834 | 23,192,866 | 2,429,705 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $29M | $35M | $29M | $19M | $12M | $4M | $59.0K | |
| Deferred Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Operating Cash Flow | $108M | $-161M | $-125M | $-70M | $-62M | $-37M | $-16M | |
| CapEx | $2M | $2M | $2M | $1M | $1M | $294.0K | $271.0K | |
| Investing Cash Flow | $-2M | $-2M | $-2M | $-1M | $-1M | $-294.0K | $-271.0K | |
| Stock Issued | · | · | · | · | · | $141M | $0 | |
| Stock Repurchased | $375M | $0 | · | · | · | · | · | |
| Net Stock Activity | $-375M | · | · | · | · | $141M | · | |
| Financing Cash Flow | $-378M | $392M | $179M | $120M | $29M | $296M | $14.0K | |
| Net Change in Cash | $-273M | $229M | $52M | $49M | $-35M | $259M | $-16M | |
| Taxes Paid | $7M | $0 | · | · | · | $0 | $256.0K | |
| Free Cash Flow | $106M | $-163M | $-127M | $-71M | $-63M | $-37M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| Net Margin | 35.7% | -5277.6% | -101319.2% | · | -292.3% | · | · | |
| Pretax Margin | 37.7% | -5269.1% | -101319.2% | · | -282.2% | · | · | |
| EBITDA Margin | 27.7% | -5939.0% | -112543.7% | · | -280.5% | · | · | |
| ROA | 18.2% | -38.0% | -45.2% | -37.2% | -22.4% | -32.4% | · | |
| ROE | 17.2% | -33.9% | -48.7% | -40.4% | -25.4% | -23.1% | · | |
| ROIC | 21.1% | -37.0% | -51.1% | -41.4% | -24.0% | -17.8% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 | 37.3 | · | |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 | 37.0 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.0 | 0.0 | 0.0 | 0.1 | 0.0 | · | |
| Receivables Turnover | 77.3 | 2.5 | 2.1 | 0.0 | 2.2 | · | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $15.51 | $14.09 | $10.43 | $10.07 | $10.14 | $11.28 | · | |
| Revenue / Share | $6.44 | $0.09 | $0.01 | $0.00 | $0.86 | · | · | |
| Cash Flow / Share | $2.84 | $-4.30 | $-4.23 | $-2.78 | $-2.66 | · | · | |
| Cash / Share | $14.71 | $13.81 | $10.40 | $10.13 | $9.60 | $11.46 | · | |
| EPS (TTM) | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 | $-2.93 | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $244M | $0 | $151.0K | $0 | $20M | $0 | · | |
| Net Income TTM | $87M | $-187M | $-153M | $-105M | $-59M | $-45M | · | |
| Market Cap | $398M | $642M | $1.27B | $1.32B | $1.40B | $1.64B | · | |
| P/E | 8.9 | -3.2 | -7.6 | -11.6 | -23.2 | -24.1 | · | |
| P/S | 1.6 | · | 8384.1 | · | 69.8 | · | · | |
| P/B | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Tangible Book | 1.3 | 1.1 | 3.8 | 4.8 | 5.8 | 6.3 | · | |
| P / Cash Flow | 3.7 | -4.0 | -10.2 | -18.9 | -22.6 | -44.3 | · | |
| P / FCF | 3.8 | -3.9 | -10.0 | -18.5 | -22.2 | -44.0 | · | |
| Earnings Yield | 11.3% | -31.6% | -13.1% | -8.6% | -4.3% | -4.2% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $32.0K | $380.0K | $14M | $18M | $211M | $0 | $0 | $0 | $0 | $143.0K | $8.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $22M | $16M | $18M | $20M | $44M | $49M | $46M | $49M | $41M | $38M | $37M | $34M | $33M | $31M | $25M | $21M | |
| SG&A Expense | $9M | $10M | $12M | $10M | $14M | $10M | $11M | $10M | $10M | $10M | $9M | $9M | $9M | $8M | $7M | $7M | |
| Operating Expenses | $31M | $26M | $30M | $30M | $58M | $59M | $56M | $59M | $50M | $49M | $47M | $43M | $41M | $39M | $32M | $28M | |
| Operating Income | $-31M | $-26M | $-29M | $-15M | $-40M | $152M | $-53M | $-59M | $-50M | $-48M | $-46M | $-43M | $-41M | $-39M | $-32M | $-28M | |
| Other Non-op | $-60.0K | $-166.0K | $273.0K | $-253.0K | $-221.0K | $-338.0K | $-229.0K | $-92.0K | $-196.0K | $-437.0K | $56.0K | $-67.0K | $-155.0K | $-40.0K | $-1M | $762.0K | |
| Pretax Income | $-29M | $-24M | $-25M | $-9M | $-33M | $158M | $-46M | $-53M | $-45M | $-43M | · | · | · | · | $-30M | $-24M | |
| Income Tax | $0 | $0 | $-2M | $-1M | $-2M | $10M | $300.0K | $0 | $0 | $0 | · | · | · | · | $0 | $0 | |
| Net Income | $-29M | $-24M | $-23M | $-7M | $-31M | $148M | $-46M | $-53M | $-45M | $-43M | $-40M | $-39M | $-38M | $-36M | $-30M | $-24M | |
| EPS (Basic) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.66 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| EPS (Diluted) | $-1.45 | $-1.21 | $-0.38 | $-0.18 | $-0.76 | $3.62 | $-1.13 | $-1.41 | $-1.25 | $-1.21 | $-1.34 | $-1.33 | $-1.27 | $-1.26 | $-1.09 | $-0.92 | |
| Shares (Basic) | 19,800,322 | 19,629,906 | · | 40,623,364 | 40,612,907 | 40,559,355 | · | 37,590,727 | 36,103,187 | 35,685,422 | · | 29,668,247 | 29,602,458 | 28,369,453 | · | 25,549,701 | |
| Shares (Diluted) | 19,800,322 | 19,629,906 | · | 40,623,364 | 40,612,907 | 41,021,325 | · | 37,590,727 | 36,103,187 | 35,685,422 | · | 29,668,247 | 29,602,458 | 28,369,453 | · | 25,549,701 | |
| EBITDA | $-31M | $-26M | · | $-15M | $-40M | $152M | · | $-59M | $-50M | $-48M | · | $-43M | $-41M | $-39M | · | $-28M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $258M | $281M | $287M | $693M | $690M | $721M | $560M | $531M | $406M | $442M | $331M | $288M | $322M | $351M | $279M | $239M | |
| Receivables | $0 | $400.0K | $4M | $3M | $16M | $17M | $3M | $388.0K | $4.0K | $226.0K | $143.0K | · | · | · | · | $0 | |
| Prepaid Expense | $7M | $7M | $22M | $22M | $27M | $22M | $26M | $21M | $27M | $20M | $16M | $17M | $12M | $11M | · | $6M | |
| Other Current Assets | $760.0K | $1M | $2M | $3M | $3M | $3M | $1M | $1M | $582.0K | $616.0K | $1M | $319.0K | $376.0K | $515.0K | · | $745.0K | |
| Current Assets | $267M | $291M | $315M | $719M | $733M | $760M | $589M | $552M | $433M | $463M | $347M | $304M | $334M | $362M | · | $246M | |
| PP&E (Net) | $4M | $4M | $4M | $5M | $5M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | $3M | $3M | · | $2M | |
| PP&E (Gross) | · | · | $9M | · | · | · | $7M | · | · | · | $6M | · | · | · | · | · | |
| Accum. Depreciation | · | · | $4M | · | · | · | $3M | · | · | · | $2M | · | · | · | · | · | |
| Other Non-current Assets | · | · | $0 | $0 | $0 | $463.0K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | · | $3M | |
| Total Assets | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Accounts Payable | $2M | $1M | $2M | $2M | $5M | $7M | $5M | $5M | $7M | $5M | $5M | $4M | $4M | $5M | · | $3M | |
| Accrued Liabilities | $8M | $9M | $16M | $15M | $20M | $17M | $21M | $22M | $14M | $13M | $18M | $12M | $12M | $11M | · | $8M | |
| Current Liabilities | $12M | $13M | $20M | $24M | $35M | $39M | $27M | $29M | $21M | $19M | $24M | $17M | $16M | $15M | · | $12M | |
| Capital Leases | $13M | $14M | $14M | $15M | $16M | $16M | $17M | $17M | $13M | $13M | $13M | $14M | $14M | $14M | · | $0 | |
| Total Liabilities | $25M | $27M | $35M | $39M | $50M | $56M | $44M | $46M | $34M | $32M | $38M | $30M | $30M | $29M | · | $12M | |
| Common Stock | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $4.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | $3.0K | · | $2.0K | |
| Paid-in Capital | $1.18B | $1.18B | $1.17B | $1.16B | $1.16B | $1.15B | $1.14B | $1.06B | $891M | $878M | $714M | $637M | $628M | $619M | · | $440M | |
| Retained Earnings | $-534M | $-505M | $-482M | $-458M | $-451M | $-420M | $-569M | $-523M | $-470M | $-425M | $-381M | $-341M | $-302M | $-264M | · | $-199M | |
| Treasury Stock | $385M | $385M | $385M | · | · | · | $0 | · | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $262M | $286M | $303M | $704M | $707M | $729M | $572M | $533M | $421M | $454M | $332M | $296M | $326M | $355M | $277M | $241M | |
| Liabilities + Equity | $288M | $312M | $338M | $743M | $757M | $785M | $616M | $579M | $455M | $486M | $370M | $326M | $356M | $384M | · | $253M | |
| Shares Outstanding | 19,827,188 | 19,732,837 | 19,543,706 | 40,632,164 | 40,615,414 | 40,562,047 | 40,554,705 | 39,258,476 | 36,169,558 | 36,067,786 | 31,841,084 | 29,679,143 | 29,661,005 | 29,548,649 | · | 26,077,204 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $5M | $6M | $7M | $4M | $9M | $9M | $9M | $9M | $9M | $8M | $7M | $9M | $7M | $6M | $5M | $5M | |
| Operating Cash Flow | $-20M | $-4M | $-27M | $3M | $-30M | $161M | $-46M | $-30M | $-40M | $-45M | $-25M | $-34M | $-31M | $-34M | $-21M | $-25M | |
| CapEx | $155.0K | $73.0K | $134.0K | $132.0K | $720.0K | $565.0K | $289.0K | $386.0K | $310.0K | $946.0K | $541.0K | $550.0K | $311.0K | $1M | $351.0K | $176.0K | |
| Investing Cash Flow | $-155.0K | $-73.0K | $-134.0K | $-132.0K | $-720.0K | $-565.0K | $-289.0K | $-386.0K | $-310.0K | $-946.0K | $-541.0K | $-550.0K | $-311.0K | $-1M | $-351.0K | $-176.0K | |
| Stock Issued | · | · | · | · | · | · | · | · | · | $151M | · | $0 | $0 | $107M | · | $48M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $151M | · | · | · | $107M | · | · | |
| Financing Cash Flow | $-3M | $-2M | $-379M | $140.0K | $17.0K | $4.0K | $76M | $156M | $4M | $157M | $69M | $284.0K | $2M | $108M | $61M | $49M | |
| Net Change in Cash | $-24M | $-6M | $-406M | $3M | $-30M | $161M | $29M | $125M | $-37M | $111M | $43M | $-34M | $-29M | $72M | $40M | $24M | |
| Free Cash Flow | · | $-4M | · | · | · | $161M | · | · | · | $-46M | · | · | · | $-35M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| Net Margin | · | -74087.5% | · | -51.5% | -169.0% | 70.3% | · | -13648.4% | -122316.2% | -51944.6% | · | -493000.0% | · | · | · | · | |
| Pretax Margin | · | -74087.5% | · | -61.6% | -181.2% | 75.0% | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | · | -80865.6% | · | -108.9% | -219.2% | 72.0% | · | -15117.8% | -136321.6% | -58413.3% | · | -541000.0% | · | · | · | · | |
| ROA | -5.5% | -4.3% | · | -1.1% | -5.1% | 23.4% | · | -11.7% | -11.2% | -9.9% | · | -13.6% | -12.9% | -11.6% | · | -9.7% | |
| ROE | -5.9% | -4.7% | · | -1.2% | -5.4% | 25.1% | · | -12.8% | -12.1% | -10.7% | · | -14.7% | -14.0% | -12.4% | · | -10.2% | |
| ROIC | -11.8% | -9.1% | · | -1.8% | -5.2% | 19.5% | · | · | · | · | · | · | · | · | · | -11.6% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 22.0 | 22.6 | · | 29.9 | 21.1 | 19.3 | · | 19.0 | 20.4 | 24.7 | · | 18.2 | 20.8 | 23.4 | · | 21.3 | |
| Quick Ratio | 21.2 | 21.9 | · | 28.9 | 20.3 | 18.7 | · | 18.3 | 19.1 | 23.6 | · | 17.2 | 20.0 | 22.7 | · | 20.8 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.3 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | · | · | · | 0.0 | |
| Receivables Turnover | 0.0 | 0.0 | · | 7.3 | 2.3 | 24.1 | · | 2.0 | 18.5 | 0.7 | · | · | · | · | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $13.23 | $14.47 | · | $17.32 | $17.40 | $17.97 | · | $13.57 | $11.64 | $12.59 | · | $9.97 | $11.00 | $12.01 | · | $9.24 | |
| Revenue / Share | $0.00 | $0.00 | · | $0.35 | $0.45 | $5.15 | · | $0.01 | $0.00 | $0.00 | · | $0.00 | · | · | · | $0.00 | |
| Cash Flow / Share | · | $-0.18 | · | · | · | $3.93 | · | · | · | $-1.25 | · | · | · | $-1.21 | · | · | |
| Cash / Share | $12.99 | $14.27 | · | $17.07 | $16.99 | $17.76 | · | $13.52 | $11.22 | $12.27 | · | $9.70 | $10.86 | $11.89 | · | $9.18 | |
| EPS (TTM) | $-3.22 | $-2.53 | · | $1.55 | $0.32 | $-0.17 | · | $-5.21 | $-5.13 | $-5.15 | · | $-4.95 | $-4.54 | $-4.40 | · | $-3.36 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $15M | $33M | · | $243M | $229M | $211M | · | $143.0K | $151.0K | $151.0K | · | $8.0K | $0 | $0 | · | · | |
| Net Income TTM | $-83M | $-85M | · | $64M | $19M | $4M | · | $-182M | $-168M | $-160M | · | $-142M | $-127M | $-116M | · | $-82M | |
| Market Cap | $212M | $218M | · | $643M | $542M | $413M | · | $2.28B | $1.65B | $2.39B | · | $946M | $1.19B | $1.26B | · | $981M | |
| P/E | -3.3 | -4.4 | · | 10.2 | 41.7 | -59.9 | · | -11.1 | -8.9 | -12.9 | · | -6.4 | -8.9 | -9.7 | · | -11.2 | |
| P/S | 14.6 | 6.7 | · | 2.6 | 2.4 | 2.0 | · | 15942.2 | 10946.7 | 15812.5 | · | 118271.4 | · | · | · | · | |
| P/B | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Tangible Book | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.6 | · | 4.3 | 3.9 | 5.3 | · | 3.2 | 3.7 | 3.6 | · | 4.1 | |
| P / Cash Flow | · | -61.7 | · | · | · | 2.6 | · | · | · | -53.6 | · | · | · | -36.9 | · | · | |
| Earnings Yield | -30.1% | -22.9% | · | 9.8% | 2.4% | -1.7% | · | -9.0% | -11.2% | -7.8% | · | -15.5% | -11.3% | -10.3% | · | -8.9% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $244M | $0 | $151.0K | $0 | $20M |
| Betriebsgewinnmarge % | 27.7% | -5939.0% | -112543.7% | · | -280.5% |
| Nettoergebnis | $87M | $-187M | $-153M | $-105M | $-59M |
| Verwässerte EPS | $2.30 | $-5.00 | $-5.20 | $-4.15 | $-2.52 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 15.5 | 21.5 | 14.2 | 17.3 | 21.2 |
| Quick Ratio | 14.3 | 20.5 | 13.6 | 16.9 | 20.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $106M | $-163M | $-127M | $-71M | $-63M |
Institutionelle Eigentümer (13F) 146 Einreicher · $234.1M gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
146
Gehaltener Wert
$234.1M
Neue Positionen
16
Geschlossene Positionen
29
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 16 (-14 vs. Vorquartal) | 29 (-7 vs. Vorquartal) | 46 (+1 vs. Vorquartal) | 49 (-8 vs. Vorquartal) | -122K |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $31.056.228 | 1.525.355 | 13,27% | Aktien |
| BlackRock, Inc. | $29.898.120 | 2.794.217 | 12,77% | Aktien |
| Nantahala Capital Management, LLC | $15.091.483 | 1.410.419 | 6,45% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $10.356.092 | 967.859 | 4,42% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $8.919.477 | 833.596 | 3,81% | Aktien |
| ORBIMED ADVISORS LLC | $8.122.959 | 759.155 | 3,47% | Aktien |
| FEDERATED HERMES, INC. | $7.494.569 | 700.427 | 3,20% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $6.983.195 | 652.635 | 2,98% | Aktien |
| MACKENZIE FINANCIAL CORP | $6.724.287 | 628.438 | 2,87% | Aktien |
| Madison Avenue Partners, LP | $6.704.438 | 626.583 | 2,86% | Aktien |
| Qube Research & Technologies Ltd | $6.514.556 | 608.837 | 2,78% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $6.478.262 | 605.445 | 2,77% | Aktien |
| STATE STREET CORP | $5.790.765 | 541.193 | 2,47% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $5.467.568 | 510.841 | 2,34% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $4.928.290 | 460.541 | 2,11% | Aktien |
| CITADEL ADVISORS LLC | $4.238.249 | 396.098 | 1,81% | Aktien |
| RENAISSANCE TECHNOLOGIES LLC | $3.842.220 | 359.086 | 1,64% | Aktien |
| TWO SIGMA ADVISERS, LP | $3.497.848 | 171.800 | 1,49% | Aktien |
| D. E. Shaw & Co., Inc. | $2.861.822 | 267.460 | 1,22% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $2.835.682 | 265.017 | 1,21% | Aktien |
| Nuveen, LLC | $2.650.989 | 247.756 | 1,13% | Aktien |
| ADAR1 Capital Management, LLC | $2.640.953 | 246.818 | 1,13% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $2.639.144 | 246.649 | 1,13% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $2.494.973 | 233.175 | 1,07% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $1.977.595 | 184.822 | 0,84% | Aktien |
| Cubist Systematic Strategies, LLC | $1.922.605 | 121.530 | 0,82% | Aktien |
| GOLDMAN SACHS GROUP INC | $1.902.953 | 177.846 | 0,81% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $1.698.218 | 158.712 | 0,73% | Aktien |
| Man Group plc | $1.664.289 | 155.541 | 0,71% | Aktien |
| WELLS FARGO & COMPANY/MN | $1.663.636 | 155.480 | 0,71% | Aktien |
| NORTHERN TRUST CORP | $1.646.121 | 153.843 | 0,70% | Aktien |
| Empowered Funds, LLC | $1.521.016 | 142.151 | 0,65% | Aktien |
| UBS Group AG | $1.476.461 | 137.987 | 0,63% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $1.405.060 | 131.314 | 0,60% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $1.368.370 | 127.885 | 0,58% | Aktien |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $1.352.255 | 126.379 | 0,58% | Aktien |
| JANE STREET GROUP, LLC | $1.233.357 | 115.267 | 0,53% | Aktien |
| Nebula Research & Development LLC | $1.206.920 | 90.406 | 0,52% | Aktien |
| Bank of New York Mellon Corp | $1.105.726 | 103.339 | 0,47% | Aktien |
| AMERIPRISE FINANCIAL INC | $1.084.360 | 101.342 | 0,46% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $906.076 | 84.680 | 0,39% | Aktien |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $902.781 | 84.372 | 0,39% | Aktien |
| MORGAN STANLEY | $848.366 | 79.286 | 0,36% | Aktien |
| Invesco Ltd. | $765.724 | 71.563 | 0,33% | Aktien |
| HSBC HOLDINGS PLC | $761.494 | 69.926 | 0,33% | Aktien |
| MARTINGALE ASSET MANAGEMENT L P | $725.418 | 67.796 | 0,31% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $682.735 | 63.807 | 0,29% | Aktien |
| RBF Capital, LLC | $671.960 | 62.800 | 0,29% | Aktien |
| AlphaQuest LLC | $653.352 | 32.090 | 0,28% | Aktien |
| Russell Investments Group, Ltd. | $651.546 | 60.892 | 0,28% | Aktien |
Aktivisten & 5%+-Eigentümer 4 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Pontifax Management 4 GP (2015) Ltd., Pontifax (Israel) IV, L.P., Pontifax (Cayman) IV, L.P., Pontifax (China) IV, L.P., Pontifax Late Stage Fund L.P., Pontifax Late Stage GP Ltd. ×3 Einreichungen | 16. Oktober 2025 | 0,00% | Änderung | · | SEC |
| ADAR1 Capital Management, LLC, ADAR1 Capital Management GP, LLC, Daniel Schneeberger ×6 Einreichungen | 15. Oktober 2025 | 0,00% | Änderung | · | SEC |
| OrbiMed Advisors LLC, OrbiMed Capital GP VII LLC, OrbiMed Genesis GP LLC, OrbiMed Capital LLC ×4 Einreichungen | 13. Dezember 2023 | · | Erste Einreichung | · | SEC |
| Arkin Bio Ventures Limited Partnership, Arkin Bio Venture Partners Ltd., Moshe Arkin, Alon Lazarus ×3 Einreichungen | 17. Dezember 2020 | · | Erste Einreichung | Vorstandskampagne | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 21 Insider · 10 Führungskräfte · 12 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Jasbir Seehra | CHIEF EXECUTIVE OFFICER | 2. April 2026 M | 440.708 | 0 | 1 | $-113.433 |
| Keith Regnante | CHIEF FINANCIAL OFFICER | 24. Februar 2026 A | 39.261 | 0 | 1 | $-77.483 |
| Christopher Rovaldi | Chief Operating Officer | 18. Februar 2025 A | 60.000 | 0 | 0 | $0 |
| Annita Tanini | Corp. Controller & VP, Finance | 18. August 2026 S | 45.144 | 0 | 1 | $-12.595 |
| Esther Cho | Chief Legal Officer | 18. August 2026 S | 35.770 | 0 | 2 | $-123.732 |
| Lorena Raquel Lerner | Chief Scientific Officer | 18. August 2026 S | 27.559 | 0 | 2 | $-100.039 |
| Yung H. Chyung | Chief Medical Officer | 18. Februar 2025 A | 44.000 | 0 | 0 | $0 |
| Simon Peter Cooper | CHIEF MEDICAL OFFICER | 13. Februar 2024 A | · | 0 | 0 | $0 |
| Jennifer Lachey | Chief Scientific Officer | 15. Juli 2022 M | 95.100 | 0 | 0 | $0 |
| Claudia Ordonez | Chief Medical Officer | 11. Juni 2021 M | 0 | 0 | 0 | $0 |
| Charles W. Newton | Direktor | 18. August 2026 S | 12.114 | 0 | 2 | $-11.197 |
| Jean Jacques Bienaime | Direktor | 17. August 2026 P | 19.592 | 6 | 0 | $75.770 |
| Anne Prener | Direktor | 1. Juli 2026 A | 13.786 | 0 | 0 | $0 |
| Julius Knowles | Direktor | 4. Juni 2026 S | 10.958 | 0 | 1 | $-28.166 |
| Nima Farzan | Direktor | 4. Juni 2026 S | 9.767 | 0 | 1 | $-28.166 |
| Alpna Seth | Direktor | 3. Juni 2026 A | 12.392 | 0 | 1 | $-28.140 |
| Mary Ann Gray | Direktor | 3. Juni 2026 A | 12.392 | 0 | 0 | $0 |
| GORDON CARL L | Direktor | 21. November 2025 D | 45.057 | 0 | 0 | $0 |
| Ran Nussbaum | Direktor | 4. Juni 2025 A | 5.250 | 0 | 0 | $0 |
| Tomer Kariv | Direktor | 4. Juni 2025 A | 5.250 | 0 | 0 | $0 |
| Alon Lazarus | Direktor | 13. April 2020 C | 2.013.102 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 23 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IWC · iShares Trust | 0,05% | 63.056 SH | 11. September 2026 | Täglich |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,03% | 6.390 SH | 2. Oktober 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,02% | 54.912 SH | 2. Oktober 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,02% | 17.295 SH | 19. August 2026 | Täglich |
| IBBQ · Invesco Exchange-Traded Fund Trust … | 0,02% | 1.424 SH | 2. Oktober 2026 | Täglich |
| IBB · iShares Trust | 0,01% | 136.946 SH | 11. September 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,01% | 86.247 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,01% | 106.081 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 16.122 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,01% | 466.203 SH | 11. September 2026 | Täglich |
| RSSL · Global X Funds | 0,01% | 8.840 NS | 31. Juli 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,00% | 49.988 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,00% | 1.300 NS | 31. Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 2.135 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 7.159 SH | 3. September 2026 | Täglich |
| DFAU · Dimensional ETF Trust | 0,00% | 4.900 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 20.827 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,00% | 220.854 SH | 19. August 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 595.316 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 980 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,00% | 49.290 SH | 19. August 2026 | Täglich |
| IWN · iShares Trust | · | 173.481 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 105.118 SH | 11. September 2026 | Täglich |
KROS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 13 Analysten
KAUF
Median-Ziel
$19.00
+67,3%
3 23,1%
Starker Kauf
6 46,2%
Kauf
4 30,8%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
6 Analysten · 2026-09-29Mittelwert-Ziel $19.83 +74,6%
← Unter allen Zielen
Aktueller Preis $11.36
Tief$16.00
Mittelwert$19.83
Hoch$25.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| KROS | $398M | 8.9 | · | 35.7% | 17.2% | · |
| IVVD | $697M | -8.2 | 110.5% | -98.2% | -36.9% | · |
| LYEL | $654M | -1.9 | -41.0% | -762355.6% | -100.3% | · |
| MGNX | $102M | -1.4 | -0.31% | -49.9% | -87.0% | · |
| RNAC | $188M | -1.4 | -92.8% | -4658.6% | 202.4% | · |
| SION | $1.84B | -21.9 | · | · | -23.4% | · |
| TRDA | $394M | -3.0 | -87.9% | -565.5% | -41.9% | · |
| WHWK | $114M | -7.3 | -72.5% | -288.3% | -13.4% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 3, 2026